Avenue Therapeutics logo
Avenue Therapeutics ATXI
$ 2.08 3.48%

Quarterly report 2024-Q3
added 11-14-2024

report update icon

Avenue Therapeutics EV/EBITDA Ratio 2011-2024 | ATXI

Annual EV/EBITDA Ratio Avenue Therapeutics

2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011
0.871 -18.8 K -5.34 -2.83 -1.22 - - - - - -

All numbers in USD currency

Indicator range from annual reports

Maximum Minimum Average
0.871 -18.8 K -3.75 K